Oramed Pharmaceuticals (ORMP) Tax Provisions (2016 - 2026)
Oramed Pharmaceuticals' (ORMP) quarterly Tax Provisions came in at $11.1 million in Q1 2026, up 1805.82% YoY from $584000.0 in Q1 2025, and up 197.65% on a QoQ basis from -$11.4 million in Q4 2025.
Oramed Pharmaceuticals (ORMP) Tax Provisions (2016 - 2026) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 6 years of Tax Provisions data on file, last reported at $11.1 million in Q1 2026.
- Quarterly Tax Provisions rose 1805.82% year-over-year to $11.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.7 million (up 183.2% YoY) and the FY2025 annual result came in at $122000.0, down 96.17% from the prior year.
- Tax Provisions improved to $11.1 million in Q1 2026, from -$11.4 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $11.1 million in Q1 2026 to a low of -$11.4 million in Q4 2025.
- A 4-year average of $1.4 million and a median of $500000.0 in 2024 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2025 — Tax Provisions sank 2839.9% — and 2026, when it jumped 1805.82%.
- Tracing ORMP's Tax Provisions over 4 years: stood at -$200000.0 in 2022, then jumped by 308.0% to $416000.0 in 2024, then slumped by 2839.9% to -$11.4 million in 2025, then soared by 197.65% to $11.1 million in 2026.
- The last three Tax Provisions figures came in at $11.1 million (Q1 2026), -$11.4 million (Q4 2025), and $11.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - | 23.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.43 Mn |
| Mar 31, 2026 | 11.13 Mn |
| Dec 31, 2025 | -11.40 Mn |
| Sep 30, 2025 | 11.06 Mn |
| Jun 30, 2025 | -126,000.00 |
| Mar 31, 2025 | 584,000.00 |
| Dec 31, 2024 | 416,000.00 |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Dec 31, 2022 | -200,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Aug 31, 2019 | -600,000.00 |
| Feb 28, 2019 | 300,000.00 |
| Nov 30, 2016 | 400,000.00 |